Our Thinking

Vaccines: the road ahead

Vaccines: the road ahead

The UK approved the first COVID-19 vaccine in early December, and the pandemic entered a new phase. While this is certainly a moment for optimism, vaccines bring new challenges around efficacy, distribution and public resistance. This week’s panel includes Caroline Naumann, Associate Director for Crisis and Security Consulting and also our COVID-19 Advisory Lead in EMEA,  and Joseph Smith, Senior Analyst responsible for providing analysis on international business issues as well as one of our leaders on analysis of the vaccine rollout.

Listen on Google Podcasts


Charles Hecker Charles Hecker
Joseph Smith Joseph Smith
Caroline Naumann Caroline Naumann

Get in touch

Can our experts help you?